| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | United States | 4 | |
| #3 | WIPO (World Intellectual Property Organization) | 3 | |
| #4 | Republic of Korea | 2 | |
| #5 | Sweden | 2 | |
| #6 | China | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Sterner Olov | 15 |
| #2 | Johansson Martin | 14 |
| #3 | Bjartell Anders | 4 |
| #4 | Hellsten Rebecka | 4 |
| #5 | Escobar Zilma | 4 |
| #6 | Martin Johansson | 2 |
| #7 | Olov Sterner | 2 |
| #8 | Martin Johanssonh | 1 |
| #9 | Gidlöf Ritha | 1 |
| #10 | Muñoz Eduardo | 1 |
| Publication | Filing date | Title |
|---|---|---|
| SE540295C2 | Sulfonamide analogues of galiellalactone | |
| SE1550735A1 | Ether analogues of galiellalactone | |
| US2017015644A1 | Tricyclic prodrugs | |
| EP2595972A1 | Tricyclic lactones for treatment of cancer |